Diligence memo · auto-generated · as of July 2, 2026

Corfigo, Inc.

Corfigo, Inc. looks fair against its niche peers and is active on financing cadence.

Diligence furtherNo decisive signal either way from the public record alone — the call needs primary diligence beyond the filings.

Businessfiled

Corfigo, Inc. operates in Other Health Care, based in Montclair.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Corfigo, Inc. has raised $5.9M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).

Largest single filing: $2.4M on 2025-12-17.

Most recent recorded round closed around 2025-12-17.

Valuation (modeled)modeled

Provath models Corfigo, Inc. at approximately $5.7M (range $2.0M–$10M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 1.33× the median modeled value of Seed Other Health Care companies in 2025–2027 (105 peers) — value vs value, same stage and era. Within the normal band (133% of peer median) for its niche.

Financing rhythm & timingmixed

Historic cadence: a new round about every 35 months.

Last raise 6 mo ago; this sector typically re-raises about every 14 months.

Raising on or ahead of the sector's normal rhythm.

The last round stepped up 1.1× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 67% of Other Health Care peers (5377 compared).

Modeled value ranks above 23% of those peers.

Closest niche peers: Xymogen, Inc., Willow Life Sciences, Inc., ManyClicks, Inc., Sterile State, Inc., Limber Prosthetics, Inc..

Peoplefiled

4 named people on file across officers, directors and signatories.

Risks & flagsmixed

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.